Triple H ODC Trial

计划入组 30 人 · 首次发布于 2019 年 8 月 1 日

Dose Escalation and Expansion Study Evaluating ODC-IL2 in Adult Patients With Advanced or Metastatic Solid Tumors

计划入组 50 人 · 首次发布于 2025 年 1 月 13 日

Cardiovascular and Metabolic Sciences Biorepository

计划入组 10,000 人 · 首次发布于 2024 年 8 月 19 日

Epoetin alfa biosimilar (LG Life Sciences)

LBVC (LG Life Sciences)

Filgrastim biosimilar (RPG Life Sciences)

Achieve Life Sciences, Inc

Canada

RPG LIFE SCIENCES LIMITED

India

SELLAS LIFE SCIENCES LIMITED

Ireland

Brazil Rises to 2nd Worldwide in Clinical Trial Recruitment, Driven by Execution and Population Diversity

BIOQuébec and Life Sciences British Columbia Form Strategic Alliance to Strengthen Canada's Life Sciences Ecosystem

Paddington Life Sciences to Lead London-Wide Life Sciences Talent Hub Backed by £3.2 Million Mayoral Investment